Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.55M Buy
21,711
+100
+0.5% +$11.5K 0.05% 328
2026
Q1
$2.37M Sell
21,611
-2,612
-11% -$289K 0.05% 311
2025
Q4
$2.67M Buy
24,223
+1,543
+7% +$170K 0.06% 290
2025
Q3
$2.53M Sell
22,680
-3,141
-12% -$330K 0.08% 234
2025
Q2
$2.72M Buy
25,821
+16,020
+163% +$1.68M 0.09% 234
2025
Q1
$1.09M Sell
9,801
-7,549
-44% -$801K 0.08% 204
2024
Q4
$1.79M Buy
+17,350
New +$1.89M 0.11% 167

Other funds holding AFL

Callan Family Office's AFL Position: Q2 2026 in Review

Callan Family Office increased its Aflac (AFL) stake by 0.46% in Q2 2026, buying an estimated $11.5K and bringing the position to 21,711 shares worth $2.55M. The position accounts for 0.05% of the portfolio, ranked #328.

Callan Family Office first reported a position in AFL in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.72M in Q2 2025. 1,702 funds tracked by Wall St. Rank hold AFL as of Q2 2026.

  • Callan Family Office held 21,711 shares of Aflac worth $2.55M as of Q2 2026.
  • Callan Family Office bought 100 Aflac shares in Q2 2026, an estimated $11.5K.
  • Aflac made up 0.05% of Callan Family Office's portfolio in Q2 2026, its #328 holding.
  • Callan Family Office first reported a position in Aflac in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Aflac position peaked at $2.72M in Q2 2025.
  • 1,702 funds tracked by Wall St. Rank held Aflac as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.